Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant with Enzalutamide
Sponsor: University of Colorado, Denver
Collaborators: United States Department of Defense